The present invention relates to compounds of Formula I, a stereoisomer, enantiomer, a pharmaceutically acceptable salt or an amino acid conjugate thereof; wherein variables are as defined herein; and their pharmaceutical compositions, which are useful as modulators of the activity of Farnesiod X receptors (FXR).
本发明涉及公式I的化合物,其立体异构体、对映异构体、药学上可接受的盐或其
氨基酸结合物;其中变量如定义所述;以及它们的药物组合物,其可用作法尼索德X受体(FXR)活性调节剂。